Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Canada-based biopharmaceutical company Theratechnologies has announced the departure of Pierre Caudrelier as chief medical officer to pursue other career opportunities.
Subscribe to our email newsletter
Dr Caudrelier joined Theratechnologies in August 2007 and worked actively in the completion of the Phase III clinical program evaluating tesamorelin in HIV-associated lipodystrophy.
Dr Caudrelier’s responsibilities will now be assumed by Christian Marsolais, vice president of clinical research and medical affairs, Martine Ortega, vice president of compliance and regulatory affairs, Pierre Perazzelli, vice president of pharmaceutical development, and Shawn Barney, acting vice president of preclinical research with these individuals reporting directly to the president and CEO of Theratechnologies.
Yves Rosconi, president and CEO of Theratechnologies., said: “On behalf of the board of directors, I would like to thank Dr Caudrelier for his time with us and wish him continued success in his future endeavors.”